Phase I Study of OSI-930 and Erlotinib in Cancer Tumors

This study has been completed.

Study NCT00603356 Information provided by Astellas Pharma Inc

First Received: December 26, 2007 Last Updated: September 26, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	July 2010
Primary Completion Date:	April 2010 (Final data collection date for primary outcome measure)